Rechercher

OncoDNA wins the Biotech Award of Deloitte's Fast 50 competition


Brussels, 27 Nov 2020. Deloitte Belgium unveiled the winners of its Fast50 competition at the Award Ceremony on 26 November 2020. The competition rewarded the 50 fastest growing and innovative technology companies headquartered and founded in Belgium. Back in 2015, OncoDNA ranked as the “Most Disruptive Innovator” in the Rising Star category, before being claimed winner of the Healthcare & Life Sciences category in 2018.


To date, OncoDNA has helped more than 20,000 patients worldwide. Our strength lies in the combination of our solutions. We not only perform complete analyses on a patient’s tumour samples, but we also provide the oncologist with a detailed report to determine the most efficient treatment at the earliest”, adds Jean-Pol Detiffe.

Over the last four years, OncoDNA has showed an outstanding sales growth of more than 180%. Despite the coronavirus health crisis, this year has opened new doors to a bright future for the biotech company. Mid-November, OncoDNA announced the success of its friendly takeover bid of IntegraGen, the French leader in DNA sequencing. This success promises to double the size of the company and triple its turnover.

  • Facebook - Gris Cercle
  • Twitter - Gris Cercle
  • LinkedIn - Gris Cercle

Inventures Investment Partners S.A. — Place Sainte-Gudule 5, 1000 Brussels, Belgium — +32 472 34 14 32 — info@inventures.fund — BE 0693.960.071

Legal Disclaimer